Pfizer completes licensing agreement with 3SBio EP News Bureau Jul 25, 2025 The agreement allows Pfizer to manufacture and commercialise 3SBio’s SSGJ-707, a bispecific antibody targeting PD-1 and VEGF…
Enzene Biosciences launches Ranibizumab to treat neovascular AMD EP News Bureau Nov 24, 2023 Ranibizumab biosimilar is the company’s seventh biosimilar
Enzene Biosciences launches Cetuximab, biosimilar of cancer drug Erbitux EP News Bureau May 29, 2023 Cetuximab is a therapeutic chimeric monoclonal antibody that is used as a targeted therapy for metastatic colorectal cancer (mCRC)…
